"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Horizon Therapeutics PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Horizon Therapeutics PLC
Horizon's NDA for Procysbi New Dosage Form Accepted by FDA
- Jul 19th, 2019 7:41 am
Is Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) A Financially Sound Company?
- Jul 19th, 2019 5:19 am
Horizon Therapeutics plc Announces U.S. FDA Acceptance of its New Drug Application to Make PROCYSBI® (Cysteamine Bitartrate) Available as Oral Granules in Packets
- Jul 18th, 2019 7:00 am
Horizon Therapeutics plc to Release Second-Quarter 2019 Financial Results and Host Webcast on Aug. 7, 2019
- Jul 16th, 2019 6:00 am
Horizon Therapeutics plc Announces Pricing of Private Offering of Senior Notes
- Jul 11th, 2019 2:45 pm
Horizon Therapeutics Files BLA to FDA for Eye Disease Drug
- Jul 11th, 2019 7:05 am
Horizon Therapeutics plc Announces Proposed Private Offering of Senior Notes
- Jul 10th, 2019 5:30 am
Horizon Therapeutics plc Submits Teprotumumab Biologics License Application (BLA) for the Treatment of Active Thyroid Eye Disease (TED)
- Jul 10th, 2019 5:00 am
Which Pharmaceutical Stocks Are Outperforming All Other Stocks?
- Jul 9th, 2019 8:11 am
Looking For Growth? Take A Look At These Biotechnology Stocks
- Jul 9th, 2019 6:00 am
Horizon Therapeutics or BioMarin: Which Is a Better Bet in July?
- Jul 3rd, 2019 10:03 am
Eyes on Graves’ Initiative Urges Action for People with Graves’ Disease and Thyroid Eye Disease
- Jun 27th, 2019 7:54 am
Is There An Opportunity With Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) 50% Undervaluation?
- Jun 23rd, 2019 8:19 am
Here’s What Hedge Funds Think About Horizon Therapeutics Public Limited Company (HZNP)
- Jun 21st, 2019 11:03 am
Horizon Therapeutics plc Initiates MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA® (pegloticase injection) in Combination with Methotrexate to Increase Response Rates and Duration of Therapy
- Jun 20th, 2019 6:00 am
See what the IHS Markit Score report has to say about Horizon Therapeutics PLC.
- Jun 18th, 2019 6:03 am
Horizon Therapeutics plc Highlights the Systemic Implications of Gout and the Need for Improved Patient Care Strategies with a Series of Presentations at EULAR 2019
- Jun 12th, 2019 6:00 am
How Should Investors Feel About Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) CEO Pay?
- Jun 8th, 2019 7:29 am
Frequently Asked Questions
Terms and Conditions
Copyright © 2019 VentureLine
Website developed by Digital Solutions